(Q43232740)

16 November 2017

Phosphorus and proton magnetic resonance spectroscopy demonstrates mitochondrial dysfunction in early and advanced Parkinson's disease (English)

1 reference

16 November 2017

1 reference

0 references

8

Rüdiger Hilker

1 reference

16 November 2017

Elke Hattingen

1

1 reference

16 November 2017

Jörg Magerkurth

2

1 reference

16 November 2017

Ulrich Pilatus

3

1 reference

16 November 2017

Anne Mozer

4

1 reference

16 November 2017

Carola Seifried

5

1 reference

16 November 2017

Helmuth Steinmetz

6

1 reference

16 November 2017

Friedhelm Zanella

7

1 reference

16 November 2017

language of work or name

English

0 references

publication date

1 December 2009

1 reference

16 November 2017

1 reference

16 November 2017

132

1 reference

16 November 2017

Pt 12

1 reference

16 November 2017

3285-3297

1 reference

Expanding insights of mitochondrial dysfunction in Parkinson's disease.

16 November 2017

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWP293

Defective brain energy metabolism shown by in vivo 31P MR spectroscopy in 28 patients with mitochondrial cytopathies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWP293

Phosphorus magnetic resonance spectroscopy in multiple system atrophy and Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWP293

Staging of brain pathology related to sporadic Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWP293

Multiple controls of oxidative metabolism in living tissues as studied by phosphorus magnetic resonance

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWP293

Neuronal laterality in Parkinson's disease with unilateral symptom by in vivo 1H magnetic resonance spectroscopy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWP293

Drosophila pink1 is required for mitochondrial function and interacts genetically with parkin

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWP293

Phosphorus magnetic resonance spectroscopy of patients with mitochondrial cytopathies demonstrates decreased levels of brain phosphocreatine

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWP293

21 January 2018

ATP and brain function

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWP293

Proton magnetic resonance spectroscopy in Parkinson's disease and atypical parkinsonian disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWP293

A comprehensive review of proton magnetic resonance spectroscopy studies in dementia and Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWP293

Use of tissue water as a concentration reference for proton spectroscopic imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWP293

The pathophysiology of mitochondrial cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWP293

Combined 1H and 31P MR spectroscopic imaging: impaired energy metabolism in severe carotid stenosis and changes upon treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWP293

Myo-inositol: a marker of reactive astrogliosis in glial tumors?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWP293

Multinuclear magnetic resonance spectroscopy for in vivo assessment of mitochondrial dysfunction in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWP293

Quantitative (31)P spectroscopic imaging of human brain at 4 Tesla: assessment of gray and white matter differences of phosphocreatine and ATP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWP293

Cortical dysfunction in non-demented Parkinson's disease patients: a combined (31)P-MRS and (18)FDG-PET study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWP293

Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWP293

Effect of wild-type or mutant Parkin on oxidative damage, nitric oxide, antioxidant defenses, and the proteasome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWP293

A randomized clinical trial of coenzyme Q10 and GPI-1485 in early Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWP293

In vivo assessment of free magnesium concentration in human brain by 31P MRS. A new calibration curve based on a mathematical algorithm.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWP293

In vivo (31)P-MRS assessment of cytosolic [Mg(2+)] in the human skeletal muscle in different metabolic conditions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWP293

Quantitative mathematical expressions for accurate in vivo assessment of cytosolic [ADP] and DeltaG of ATP hydrolysis in the human brain and skeletal muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWP293

Lactate quantification by proton magnetic resonance spectroscopy using a clinical MRI machine: a basic study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWP293

Parkinson's disease brain mitochondrial complex I has oxidatively damaged subunits and is functionally impaired and misassembled.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWP293

Brain and muscle energy metabolism studied in vivo by 31P-magnetic resonance spectroscopy in NARP syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWP293

Absolute concentrations of metabolites in the adult human brain in vivo: quantification of localized proton MR spectra.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWP293

Brain 31P-magnetic resonance spectroscopy in mitochondrial cytopathies

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWP293

Quantitative 1H magnetic resonance spectroscopy and MRI of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWP293

Mitochondrial dysfunction and oxidative damage in parkin-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWP293

Cerebral metabolism in hyper- and hypocarbia: 31P and 1H nuclear magnetic resonance studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWP293

Cerebral energy metabolism in phenylketonuria: findings by quantitative In vivo 31P MR spectroscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWP293

Mutation in the alpha-synuclein gene identified in families with Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWP293

Lactate rise detected by 1H NMR in human visual cortex during physiologic stimulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWP293

Oxidative phosphorylation: kinetic and thermodynamic correlation between electron flow, proton translocation, oxygen consumption and ATP synthesis under close to in vivo concentrations of oxygen

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWP293

Magnetic resonance spectroscopy of the human brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWP293

Evidence for mitochondrial dysfunction in Parkinson's disease--a critical appraisal

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWP293

Mitochondria in the aetiology and pathogenesis of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWP293

Mitochondrial complex I deficiency in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWP293

Mitochondrial localization of alpha-synuclein protein in alpha-synuclein overexpressing cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWP293

Effects of coenzyme Q10 in early Parkinson disease: evidence of slowing of the functional decline

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWP293

In vivo evidence for cerebral depletion in high-energy phosphates in progressive supranuclear palsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWP293

Short-term effects of coenzyme Q10 in progressive supranuclear palsy: a randomized, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWP293

Randomized, double-blind, placebo-controlled trial on symptomatic effects of coenzyme Q(10) in Parkinson disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWP293

Proton magnetic resonance spectroscopic imaging in progressive supranuclear palsy, Parkinson's disease and corticobasal degeneration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWP293

Improved method for accurate and efficient quantification of MRS data with use of prior knowledge

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWP293

Hereditary early-onset Parkinson's disease caused by mutations in PINK1

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWP293

A mitochondrial paradigm of metabolic and degenerative diseases, aging, and cancer: a dawn for evolutionary medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWP293

Combination therapy with coenzyme Q10 and creatine produces additive neuroprotective effects in models of Parkinson's and Huntington's diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWP293

Mitochondrial complex I and II activities of lymphocytes and platelets in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWP293

21 January 2018

Identifiers

DOI

10.1093/BRAIN/AWP293

1 reference

16 November 2017

1 reference